CD274 and neoplasm: The main biomarkers for predicting the efficacy of traditional immunotherapy mainly refer to the expression level of PD-L1 in the TME, including the expression of PD-L1 in tumor cells and immune cells, as well as TMB and microsatellite instability (MSI).